Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection
A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19...
Saved in:
| Main Authors: | Rebecca A. Ocher, Erika Padilla, Jonathan C. Hsu, Pam R. Taub |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Case Reports in Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2021/7809231 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Postural Orthostatic Tachycardia Syndrome (POTS) – A Review of Pathophysiological Mechanisms, Diagnosis and Therapy
by: Alicja Dziedzic, et al.
Published: (2024-11-01) -
A unique manifestation of postural orthostatic tachycardia syndrome (POTS) resembling symptoms of irritable bowel syndrome
by: Alshmandi Mohamed, et al.
Published: (2024-01-01) -
From Postural Orthostatic Tachycardia Syndrome to Radiologically Isolated Syndrome
by: Richa Tripathi, et al.
Published: (2018-01-01) -
Narrative Review of Postural Orthostatic Tachycardia Syndrome: Associated Conditions and Management Strategies
by: Rebecca S Steinberg, et al.
Published: (2023-09-01) -
Pathophysiological mechanisms of Postural Orthostatic Tachycardia Syndrome analyzed by means of hemodynamics.
by: Liuchuang Wei, et al.
Published: (2025-01-01)